Vincristine Sulfate Liposomes Injection
Showing 1 - 25 of >10,000
Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- Vincristine Sulfate Liposomes Injection (VSLI)
- Vincristine Sulfate Injection (VSI)
-
La Jolla, California
- +14 more
Sep 6, 2021
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Marqibo® (vincristine sulfate liposomes injection)
-
Los Angeles, California
- +32 more
Feb 8, 2021
Malignant Melanoma Trial in Houston (Vincristine Sulfate Liposomes Injection)
Completed
- Malignant Melanoma
- Vincristine Sulfate Liposomes Injection
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
Dec 10, 2019
Sarcoma, Neuroblastoma, Wilms Tumor Trial run by the (Marqibo)
Completed
- Sarcoma
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2020
Acute Lymphoblastic Leukemia Trial in Atlanta, Chicago, Houston (Vincristine Sulfate Liposomes Injection, Dexamethasone)
Completed
- Acute Lymphoblastic Leukemia
- Vincristine Sulfate Liposomes Injection
- Dexamethasone
-
Atlanta, Georgia
- +2 more
Dec 10, 2019
Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in San Francisco, Leeds (Vincristine Sulfate
Completed
- Non-Hodgkin's Lymphoma
- +2 more
- Vincristine Sulfate Liposome Injection plus rituximab
-
San Francisco, California
- +1 more
Dec 31, 2019
Metastatic Malignant Uveal Melanoma Trial in United States (Marqibo® (vincristine sulfate liposomes injection))
Completed
- Metastatic Malignant Uveal Melanoma
- Marqibo® (vincristine sulfate liposomes injection)
-
Los Angeles, California
- +3 more
Nov 27, 2019
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +5 more
- Rituximab
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Jul 19, 2021
Intraocular Retinoblastoma Trial in United States (drug, procedure, biological)
Completed
- Intraocular Retinoblastoma
- liposomal vincristine sulfate
- +5 more
-
Arcadia, California
- +10 more
Jul 12, 2021
Locally Advanced Sarcoma Trial in Houston (Dexamethasone, Doxorubicin, Fosaprepitant Dimeglumine)
Terminated
- Locally Advanced Sarcoma
- Dexamethasone
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Aug 5, 2021
Hematologic Diseases Trial (Vincristine Sulfate Liposome, CHOP, R-CHOP)
Unknown status
- Hematologic Diseases
- Vincristine Sulfate Liposome
- +2 more
- (no location specified)
Apr 15, 2020
Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in
Active, not recruiting
- Stage I Mantle Cell Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Buffalo, New York
- +1 more
Mar 9, 2022
Intraocular Retinoblastoma Trial in Worldwide (liposomal vincristine sulfate, carboplatin, etoposide)
Completed
- Intraocular Retinoblastoma
- liposomal vincristine sulfate
- +2 more
-
Birmingham, Alabama
- +55 more
Feb 16, 2021
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Cyclophosphamide
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 18, 2022
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Recurrent Adult Acute Myeloid Leukemia Trial in Winston-Salem (Vincristine Sulfate Liposome, Laboratory Biomarker Analysis)
Terminated
- Recurrent Adult Acute Myeloid Leukemia
- Vincristine Sulfate Liposome
- Laboratory Biomarker Analysis
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 31, 2019
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5
Withdrawn
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +7 more
- Inotuzumab Ozogamicin
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 13, 2022
Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,
Suspended
- Alveolar Rhabdomyosarcoma
- +5 more
- Cyclophosphamide
- +8 more
-
Birmingham, Alabama
- +386 more
Aug 18, 2022
Localized Extraskeletal Ewing Sarcoma, Peripheral Primitive Neuroectodermal Tumor of Bone, Peripheral Primitive Neuroectodermal
Active, not recruiting
- Localized Extraskeletal Ewing Sarcoma
- +2 more
- Cyclophosphamide
- +7 more
-
Birmingham, Alabama
- +242 more
May 19, 2022
Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult
Completed
- Contiguous Stage II Adult Lymphoblastic Lymphoma
- +5 more
- carfilzomib
- +10 more
-
Sacramento, CaliforniaUniversity of California Davis
Mar 8, 2022
Chronic Pain Trial in Minia (epidural transforaminal injection of magnesuim sulfate, epidural transforaminal injection of
Recruiting
- Chronic Pain
- epidural transforaminal injection of magnesuim sulfate
- +2 more
-
Minia, Minia University Hospital, EgyptMinia University
May 7, 2022